MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFR therapeutics

Aksoy S., Kanat O., Tunca B., Ertas H., Ugras N., Ozturk E., ...More

International Congress on Targeted Anticancer Therapies (TAT), Paris, France, 5 - 07 March 2018, vol.29, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 29
• City: Paris
• Country: France
• Bursa Uludag University Affiliated: Yes